Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Scudder Kemper Investments was a prominent American asset management firm formed in 1997 through the merger of Scudder, Stevens & Clark and the asset management unit of Kemper Corporation. The firm provided a broad suite of investment products, including mutual funds, institutional asset management, and private wealth services to clients globally. Although the firm managed various sector-specific portfolios, including healthcare and life sciences funds, its primary business was financial services rather than biotechnology research or drug development. In 2002, the company was acquired by Deutsche Bank from Zurich Financial Services, and its operations were subsequently integrated into Deutsche Asset Management, which now operates as DWS Group.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Scudder Kemper Investments.